Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer20 Jun ETF JUNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677K Buy
19,697
+3,289
+20% +$112K ﹤0.01% 2472
2026
Q1
$547K Buy
16,408
+979
+6% +$32.8K ﹤0.01% 2712
2025
Q4
$515K Hold
15,429
﹤0.01% 2694
2025
Q3
$506K Sell
15,429
-178
-1% -$5.75K ﹤0.01% 2673
2025
Q2
$497K Buy
15,607
+8,519
+120% +$258K ﹤0.01% 2555
2025
Q1
$211K Sell
7,088
-25
-0.4% -$755 ﹤0.01% 3167
2024
Q4
$214K Buy
+7,113
New +$213K ﹤0.01% 3139
2024
Q3
Sell
-75,347
Closed -$2.15M 3478
2024
Q2
$2.15M Buy
+75,347
New +$2.12M 0.01% 1236

Other funds holding JUNW

Cambridge Investment Research Advisors's JUNW Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its AllianzIM U.S. Equity Buffer20 Jun ETF (JUNW) stake by 20% in Q2 2026, buying an estimated $112K and bringing the position to 19,697 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

Cambridge Investment Research Advisors first reported a position in JUNW in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.15M in Q2 2024. 30 funds tracked by Wall St. Rank hold JUNW as of Q2 2026.

  • Cambridge Investment Research Advisors held 19,697 shares of AllianzIM U.S. Equity Buffer20 Jun ETF worth $677K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,289 AllianzIM U.S. Equity Buffer20 Jun ETF shares in Q2 2026, an estimated $112K.
  • AllianzIM U.S. Equity Buffer20 Jun ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2472 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer20 Jun ETF in Q2 2024 and has held it in 8 quarters since.
  • Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer20 Jun ETF position peaked at $2.15M in Q2 2024.
  • 30 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Jun ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.